Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biogen Idec Buys Stromedix, Bringing IPF Candidate Full Circle

Feb 14 2012

Related Content

BMS Bets On Amira's IPF Drug In $325M Acquisition

Jul 22 2011

Energized Biogen Idec On Track For Two Filings In 2012

Jan 31 2012

Promedior and Stromedix Spot Fresh Approaches in Fibrosis

May 01 2008

InterMune Launches Esbriet in Germany At Better-Than-Expected Price

Sep 14 2011

Pleasant Surprise For InterMune With Early Positive Opinion On Pirfenidone From CHMP

Dec 17 2010

Related Companies

Biogen, Inc.

Stromedix, Inc.

Bristol Myers Squibb Company

Gilead Sciences, Inc.

Gilead Sciences, Inc.

InterMune, Inc.

Additional Topics

Business Strategies Clinical Trials Deals BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window